首页> 外文期刊>Diagnostic microbiology and infectious disease >Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.
【24h】

Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.

机译:1996年至2002年中国重症监护病房患者革兰氏阴性菌临床分离株中的耐药性监测。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective is to investigate the trend of antimicrobial resistance among nosocomial gram-negative bacteria isolated from intensive care units in China. From 1996 to 2002, the minimum inhibitory concentrations (MICs) of 8 antibiotics for 10,585 isolates of gram-negative bacteria from 19 hospitals in 7 central cities were determined by Etest. From 1996 to 2002, a marked decrease in the susceptibility of Pseudomonas aeruginosa to imipenem was noticed along the years (81-62%). Percentage of multidrug resistance of strains in P. aeruginosa obviously increased (11.5% in 1996, 20.5% in 2002). Imipenem kept active against Escherichia coli (99.2-100% susceptible), Acinetobacter spp. (97.6-93.5%), Klebsiella spp. (94.9-100%), Enterobacter spp. (89-96%). Resistance to cephalosporins, ciprofloxacin, and cefoperazone/sulbactam was observed, particularly among E. coli to ciprofloxacin (42-25%) and cefotaxime (78-54%) and Enterobacter spp. to ceftazidime (51-44%) and cefotaxime (50-37%). Piperacillin/tazobactam kept stable and active against P. aeruginosa, E. coli, and Klebsiella spp. (80%), with an increasing trend, but not good, in Enterobacter spp. (63-58%). Extended-spectrum beta-lactamase-producing strains in E. coli (28.6-45.7%) and Klebsiella spp. (25.5-34.9%) increased during 2001-2002. There was no significant increase resistance in Enterobacteriaceae isolates and Acinetobacter spp. to imipenem, but it has obviously decreased activity in P. aeruginosa throughout the 7-year period in China. Resistance of tested gram-negative bacteria to most comparator antimicrobials increased at different levels from 1996 to 2002 in China.
机译:目的是研究从中国重症监护病房分离出的医院内革兰氏阴性菌的耐药性趋势。从1996年到2002年,通过Etest确定了来自7个中心城市的19家医院的10,585株革兰氏阴性细菌分离物中8种抗生素的最低抑菌浓度(MICs)。从1996年到2002年,这些年来铜绿假单胞菌对亚胺培南的敏感性显着下降(81-62%)。铜绿假单胞菌菌株对多药耐药的百分比明显增加(1996年为11.5%,2002年为20.5%)。亚胺培南对大肠杆菌(不敏感的99.2-100%),不动杆菌属保持活性。 (97.6-93.5%),克雷伯菌属。 (94.9-100%),肠杆菌属。 (89-96%)。观察到对头孢菌素,环丙沙星和头孢哌酮/舒巴坦的耐药性,特别是在大肠杆菌中对环丙沙星(42-25%)和头孢噻肟(78-54%)和肠杆菌属的耐药。到头孢他啶(51-44%)和头孢噻肟(50-37%)。哌拉西林/他唑巴坦对铜绿假单胞菌,大肠杆菌和克雷伯菌属保持稳定并具有活性。 (80%),肠杆菌属菌种呈上升趋势,但不好。 (63-58%)。在大肠杆菌(28.6-45.7%)和克雷伯菌属中产生超广谱β-内酰胺酶的菌株。 (25.5-34.9%)在2001-2002年期间增长。在肠杆菌科细菌和不动杆菌属中没有明显的耐药性增加。与亚胺培南相比,在整个中国的7年中,铜绿假单胞菌的活性明显降低。从1996年到2002年,中国检测到的革兰氏阴性菌对大多数比较药物的耐药性有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号